Back
Vir Biotechnology Vs. GlycoMimetics Industry Stock Comparison
Sell
19
VIR
Vir Biotechnology
Last Price:
8.64
Seasonality Move:
40.05%
Buy
71
GLYC
GlycoMimetics
Last Price:
0.41
Seasonality Move:
49.38%
Sell
19
Vir Biotechnology (VIR)
is a Sell
Is Vir Biotechnology a Buy, Sell or Hold?
- The current Vir Biotechnology [VIR] share price is $8.98. The Score for VIR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- VIR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
GlycoMimetics (GLYC)
is a Buy
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.40. The Score for GLYC is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GLYC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VIR Stock Price Chart
What is Vir Biotechnology's stock price today?
-
The Vir Biotechnology share price today is $8.98
The current trend is moderately bearish and VIR is experiencing selling pressure, which indicates risk of future bearish movement.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLYC is experiencing slight selling pressure.
VIR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 55.65 | Buy |
| Chaikin Money Flow: | -637561 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.31 - 9.27) | Buy |
| Bollinger Bands (100): | (7.58 - 9.48) | Buy |
GLYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 65.14 | Buy |
| Chaikin Money Flow: | -142211 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.15 - 0.41) | Buy |
| Bollinger Bands (100): | (0.14 - 0.32) | Buy |
VIR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.58 | Sell |
| 20-day SMA: | 8.47 | Buy |
| 50-day SMA: | 7.98 | Buy |
| 200-day SMA: | 9.22 | Sell |
| 8-day EMA: | 9.26 | Sell |
| 20-day EMA: | 8.74 | Buy |
| 50-day EMA: | 8.38 | Buy |
| 200-day EMA: | 9.53 | Sell |
GLYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.4 | Sell |
| 20-day SMA: | 0.31 | Buy |
| 50-day SMA: | 0.22 | Buy |
| 200-day SMA: | 1.06 | Sell |
| 8-day EMA: | 0.4 | Buy |
| 20-day EMA: | 0.34 | Buy |
| 50-day EMA: | 0.27 | Buy |
| 200-day EMA: | 0.76 | Sell |
Vir Biotechnology Earnings Growth & VIR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.10 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Vir Biotechnology Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
GlycoMimetics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||